A detailed history of Apeiron Capital LTD transactions in Staar Surgical CO stock. As of the latest transaction made, Apeiron Capital LTD holds 237,130 shares of STAA stock, worth $6.9 Million. This represents 6.44% of its overall portfolio holdings.

Number of Shares
237,130
Previous 247,120 4.04%
Holding current value
$6.9 Million
Previous $11.8 Million 25.13%
% of portfolio
6.44%
Previous 10.19%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$29.97 - $47.42 $299,400 - $473,725
-9,990 Reduced 4.04%
237,130 $8.81 Million
Q2 2024

Aug 08, 2024

SELL
$38.07 - $52.25 $3.97 Million - $5.44 Million
-104,192 Reduced 29.66%
247,120 $11.8 Million
Q1 2024

Apr 11, 2024

SELL
$27.67 - $39.61 $11,068 - $15,844
-400 Reduced 0.11%
351,312 $13.4 Million
Q3 2023

Oct 31, 2023

SELL
$39.39 - $58.12 $1.71 Million - $2.52 Million
-43,441 Reduced 10.99%
351,712 $14.1 Million
Q2 2023

Jul 24, 2023

SELL
$50.45 - $72.82 $6.45 Million - $9.31 Million
-127,872 Reduced 24.45%
395,153 $20.8 Million
Q1 2023

Apr 24, 2023

BUY
$51.25 - $79.34 $9.5 Million - $14.7 Million
185,386 Added 54.91%
523,025 $33.4 Million
Q4 2022

Jan 17, 2023

SELL
$46.82 - $76.2 $3.25 Million - $5.29 Million
-69,461 Reduced 17.06%
337,639 $0
Q4 2021

Jan 26, 2022

BUY
$88.02 - $127.79 $1.24 Million - $1.8 Million
14,100 Added 3.59%
407,100 $37.2 Million
Q3 2021

Oct 29, 2021

BUY
$122.75 - $162.68 $3.19 Million - $4.23 Million
26,000 Added 7.08%
393,000 $50.5 Million
Q1 2021

Apr 12, 2021

BUY
$78.5 - $126.48 $4.08 Million - $6.58 Million
52,000 Added 16.51%
367,000 $38.7 Million
Q4 2020

Jan 29, 2021

BUY
$55.93 - $82.78 $17.6 Million - $26.1 Million
315,000 New
315,000 $25 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.4B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Apeiron Capital LTD Portfolio

Follow Apeiron Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apeiron Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Apeiron Capital LTD with notifications on news.